High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer
High PD-L1 expression serves as an independent adverse prognostic biomarker in stage III but not stage II G/GEJC. These findings indicate a stage-dependent prognostic value of PD-L1 expression in G/GEJC.
Authors
- Fengping Li (ORCID: https://orcid.org/0000-0002-8535-112X)
- Xuefeng Zhong
- Rou Zhong
- Xinhua Chen (ORCID: https://orcid.org/0000-0002-1879-4318)
- Li-Ying Zhao
- Qing Xie
- Xiao Yan
- Hao Liu
- Hui-Min Zhang
- Min Lai
- Heng-Yi Zhang
- Hua-Yuan Liang
- Xin-Ru Liu
Institutions
- Shanghai Medical Information Center (CN)
- Nanfang Hospital (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Southern Medical University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2026-02-10
- DOI
- https://doi.org/10.3748/wjg.v32.i8.115333
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00